REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

BioGend Therapeutics Co., Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: BioGend Therapeutics Co., Ltd. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

BioGend Therapeutics Co., Ltd. is mainly engaged in the development of bone and cartilage repair. The company was founded in 2016 and is headquartered in New Taipei City, Taiwan.

Headquarters
4F, No.3, Yuang St.Nangang District
Taipei City; Taipei City;

Contact Details: Purchase the BioGend Therapeutics Co., Ltd. report to view the information.

Website: http://www.biogend.com.tw

Basic Information
Total Employees:
Purchase the BioGend Therapeutics Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the BioGend Therapeutics Co., Ltd. report to view the information.
Financial Auditors:
Purchase the BioGend Therapeutics Co., Ltd. report to view the information.
Incorporation Date:
July 07, 2016
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
30.53%
Purchase this report to view the information.
3.08%
Purchase this report to view the information.
0.66%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
山東博升生物技術有限公司
100%
Osteopharma Inc. (Japan)
46.73%
Company Performance
Financial values in the chart are available after BioGend Therapeutics Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
47.77%▲
Total operating revenue
46.76%▲
Operating profit (EBIT)
26.96%▲
EBITDA
34.76%▲
Net Profit (Loss) for the Period
30.16%▲
Total assets
-13.64%▼
Total equity
-13.05%▼
Operating Profit Margin (ROS)
86.6%▲
Net Profit Margin
82.82%▲
Return on Equity (ROE)
1.45%▲
Quick Ratio
-1.04%▼
Cash Ratio
-6.83%▼

Similar companies

Lotus Pharmaceutical Co., Ltd.
 
Great Tree Pharmacy Co.,Ltd.
Bora Pharmaceuticals Co., Ltd.
 
China Chemical & Pharmaceutical Co., Ltd
PharmaEssentia Corp.
 
Pharmally International Holding Co., Ltd
Uni Pharma Co., Ltd.
 
Taiwan Liposome Company, Ltd.
ASLAN Pharmaceuticals Limited
 
Taiwan Bio Therapeutics Co., Ltd.
Tekho Marine Biotech Co., Ltd. (Tainan City) (德河海洋生技股份有限公司 (台南市))
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo